|1|Antihypertensive treatment and resistant hypertension in patients with type 1 diabetes by stages of diabetic nephropathy. (24170765)
Lithovius R.... Groop P.H.
|2|Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy. (24049285)
Goswami R.P.... Ghosh A.
|3|Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. (22832513)
Lipkowitz M.S.... Kopp J.B.
|4|Functional expression of TRPV4 channels in human collecting duct cells: implications for secondary hypertension in diabetic nephropathy. (23049542)
Hills C.E.... Squires P.E.
|5|Pathogenesis and management of renovascular hypertension and ischemic nephropathy. (22402318)
Yerram P.... Chaudhary K.
|6|Hemolytic-uremic syndrome, malignant hypertension and IgA nephropathy: successful treatment with plasma exchange therapy. (22892290)
Pipili C.... Grapsa E.
|7|Common genetic variants in the chromogranin a promoter are associated with renal injury in IgA nephropathy patients with malignant hypertension. (20113265)
Yu L.... Zhang H.
|8|Association of the SLC22A1, SLC22A2, and SLC22A3 genes encoding organic cation transporters with diabetic nephropathy and hypertension. (20429798)
Sallinen R.... Wessman M.
|9|Renovascular hypertension and ischemic nephropathy. (20864945)
Textor S.C.... Lerman L.
|10|Malignant hypertension associated with IgA nephropathy. (20840215)
Zotos P.... Toumanidis S.
|11|The role of the renin-angiotensin-aldosterone system in renal artery stenosis, renovascular hypertension, and ischemic nephropathy: diagnostic implications. (19917331)
Covic A.... Gusbeth-Tatomir P.
|12|Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy. (19749494)
Sasaki H.... Shirai K.
|13|Polymorphism of the aldosterone synthase gene is not associated with progression of diabetic nephropathy, but associated with hypertension in type 2 diabetic patients. (18771471)
Ko G.J.... Cha D.R.
|14|Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions. (18603547)
Jiang L.... Zhang H.
|15|Irbesartan: a review of its use in hypertension and diabetic nephropathy. (18627212)
Croom K.F.... Plosker G.L.
|16|Idiopathic membranous nephropathy complicated with malignant hypertension: a case report. (17711746)
Tao J.L.... Li X.W.
|17|Imidapril: a review of its use in essential hypertension, Type 1 diabetic nephropathy and chronic heart failure. (17547476)
Robinson D.M.... Lyseng-Williamson K.A.
|18|The link between Glut-1 and hypertension in diabetic nephropathy. (16600163)
Gnudi L.... Raij L.
|19|Renal expression and localization of the facilitative glucose transporters GLUT1 and GLUT12 in animal models of hypertension and diabetic nephropathy. (16091581)
Linden K.C.... Rogers S.
|20|Malignant hypertension in patients with idiopathic IgA nephropathy. (16340218)
Chen Y.... Li L.S.
|21|Retarding the progression of diabetic nephropathy in type 2 diabetes mellitus: focus on hypertension and proteinuria. (15726216)
|22|Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy. (15101793)
Croom K.F.... Perry C.M.
|23|Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria. (15485418)
Anavekar N.S.... Pfeffer M.A.
|24|Case 4: eruption on the face of a diabetic man suffering from retinopathy, hypertension, and nephropathy. Diagnosis: ciclosporin-associated hyperplastic folliculitis. (12780737)
Harman K.E.... Higgins E.M.
|25|Insulin resistance highly associates with hypertension in IgA nephropathy. (12608549)
Eiro M.... Watanabe T.
|26|Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension. (12540629)
Kelly D.J.... Gilbert R.E.
|27|Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes. (12716755)
Jaffa A.A.... Schmaier A.H.
|28|Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors. (12477155)
Crook E.D.... Preddie D.C.
|29|Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy]. (12154518)
JovanoviA8 D.B.... DjukanoviA8 L.
|30|G protein beta 3 subunit 825T allele, hypertension, obesity, and diabetic nephropathy. (10978382)
|31|The ACE inhibitor spirapril in chronic renal failure, hypertension and diabetic nephropathy]. (11220886)
|32|G-Protein beta(3) subunit C825T variant, nephropathy and hypertension in patients with type 2 (Non-insulin-dependent) diabetes mellitus. (10970984)
Zychma M.J.... Grzeszczak W.
|33|Inhibitory effects of a subdepressor dose of L-158,809, an angiotensin II type 1 receptor antagonist, on cardiac hypertrophy and nephropathy via the activated human renin-angiotensin system in double transgenic mice with hypertension. (9741738)
Kai T.... Ishikawa K.
|34|Beta3-adrenergic receptor gene polymorphism is not associated with hypertension in NIDDM patients without nephropathy. (9851671)
Baba T.... Yajima Y.
|35|Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy. (9631840)
Nieuwhof C.... van Breda Vriesman P.J.
|36|Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients. (9519751)
Fagerudd J.A.... Groop P.H.
|37|Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control. (9084972)
Barnas U.... Mayer G.
|38|Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension. (9049480)
Ringel J.... Sharma A.M.
|39|Insulin resistance, hypertension and nephropathy. (9240760)
Kikkawa R.... Kojima H.
|40|Effect of chronic intermittent intravenous insulin therapy on antihypertensive medication requirements in IDDM subjects with hypertension and nephropathy. (8612440)
Aoki T.T.... Meisenheimer R.
|41|Predictors for hypertensive nephropathy: results of a 6-year follow-up study in essential hypertension. (7622857)
Schmieder R.E.... SchAochinger H.
|42|Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy. (8216441)
BAPnner G.... Stumpe K.O.
|43|Red blood cell Li+/Na+ exchange in patients with diabetic nephropathy and essential hypertension: therapeutic implications. (8516486)
Semplicini A.... Pessina A.C.
|44|Management of renal disease and hypertension in insulin-dependent diabetes, with an emphasis on early nephropathy. (1365821)
|45|Recent advances in pharmacological management of hypertension in diabetic patients with nephropathy. Effects of antihypertensive drugs on kidney function and insulin sensitivity. (1377114)
Baba T.... Ishizaki T.
|46|Predisposition to essential hypertension and the development of diabetic nephropathy. (1457758)
Viberti G.C.... Earle K.
|47|Should ACE inhibitors be the drugs of choice in the treatment of hypertension in diabetes mellitus? ACE inhibitors are the drugs of choice in diabetic nephropathy. (1887338)
Huddle K.... Milne F.J.
|48|Malignant hypertension due to reflux nephropathy in an adolescent (a case report). (1784033)
Ravat S.H.... Pahlajani D.B.
|49|Idiopathic IgA nephropathy presenting as malignant hypertension. (3565507)
Perez-Fontan M.... Sicilia L.S.
|50|Bilateral nephrectomy and chronic hemodialysis in renal failure due to diabetic nephropathy complicated by malignant hypertension and cerebral edema. (683408)
Nik-Akhtar B.... Khonsari H.